Literature DB >> 9419408

Aggressiveness of colon carcinoma in blacks and whites. National Cancer Institute Black/White Cancer Survival Study Group.

V W Chen1, C M Fenoglio-Preiser, X C Wu, R J Coates, P Reynolds, D L Wickerham, P Andrews, C Hunter, G Stemmermann, J S Jackson, B K Edwards.   

Abstract

Black patients with colon cancer in the Black/White Cancer Survival Study were found to have a poorer survival than white patients. More advanced-stage disease at diagnosis was the primary determinant, accounting for 60% of the excess mortality. After adjusting for stage, factors such as poverty, other socioeconomic conditions, and treatment did not further explain the remaining survival deficit. This study examined the aggressiveness of colon tumors in blacks and whites to explore its role in the racial survival differences. Tumor characteristics of 703 cases of newly diagnosed invasive colon adenocarcinoma were centrally evaluated by a gastrointestinal pathologist, blinded in regard to the age, race, and sex of the patients. Blacks were less likely to have poorly differentiated (grade 3) tumors [odds ratio (OR), 0.44; 95% confidence interval, 0.22-0.88] and lymphoid reaction (OR, 0.49; 95% confidence interval, 0.26-0.90) when compared with whites. These black/white (B/W) differences remained statistically significant after adjusting for age, sex, metropolitan area, summary stage, socioeconomic status, body mass index, and health care access and utilization. In addition, blacks were less likely to have high-grade (grade 3) nuclear atypia, mitotic activity, and tubule formation, although these ORs did not reach a statistical significance level of 0.05. Similar B/W differences were observed for patients with advanced disease but not with early stage. Comparison by anatomical subsite showed that blacks had statistically significantly better differentiated tumors for cancers of the proximal and transverse colon but not for the distal. No racial differences were found for blood vessel and lymphatic invasion, necrosis, fibrosis, and mucinous type of histology. The findings, therefore, are the opposite of those hypothesized. After adjusting for stage, more aggressive tumor characteristics do not explain the adverse survival differential in blacks. This suggests that there may be racial differences in environmental exposure, and that the intensity and mode of delivery of carcinogen insult as well as host susceptibility may differ by race and anatomical subsite. Future studies should explore the B/W differences in tumor biology using molecular markers that precede the conventional histological parameters evaluated here.

Entities:  

Mesh:

Year:  1997        PMID: 9419408

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  36 in total

Review 1.  Social, prognostic, and therapeutic factors associated with cancer survival: a population-based study in metropolitan Detroit, Michigan.

Authors:  Kevin M Gorey; Eric J Holowaty; Ethan Laukkanen; Isaac N Luginaah
Journal:  J Health Care Poor Underserved       Date:  2003-11

2.  Racial disparities in stage-specific colorectal cancer mortality: 1960-2005.

Authors:  Samir Soneji; Shally Shalini Iyer; Katrina Armstrong; David A Asch
Journal:  Am J Public Health       Date:  2010-08-19       Impact factor: 9.308

3.  Telephone outreach to increase colorectal cancer screening in an urban minority population.

Authors:  Charles E Basch; Randi L Wolf; Corey H Brouse; Celia Shmukler; Alfred Neugut; Lawrence T DeCarlo; Steven Shea
Journal:  Am J Public Health       Date:  2006-10-31       Impact factor: 9.308

Review 4.  Colonoscopic screening for colon cancer.

Authors:  K A Forde
Journal:  Surg Endosc       Date:  2006-03-16       Impact factor: 4.584

5.  The frequency of early repeat tests after colonoscopy in elderly medicare recipients.

Authors:  Robert J Richards; Stephen Crystal
Journal:  Dig Dis Sci       Date:  2009-02-25       Impact factor: 3.199

6.  High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas.

Authors:  Dominik Alexander; Nirag Jhala; Chakrapani Chatla; Jon Steinhauer; Ellen Funkhouser; Christopher S Coffey; William E Grizzle; Upender Manne
Journal:  Cancer       Date:  2005-05-15       Impact factor: 6.860

7.  Occult tumor burden contributes to racial disparities in stage-specific colorectal cancer outcomes.

Authors:  Terry Hyslop; David S Weinberg; Stephanie Schulz; Alan Barkun; Scott A Waldman
Journal:  Cancer       Date:  2011-09-01       Impact factor: 6.860

Review 8.  Guanylyl cyclase C as a biomarker in colorectal cancer.

Authors:  Terry Hyslop; Scott A Waldman
Journal:  Biomark Med       Date:  2013-02       Impact factor: 2.851

9.  Barriers and facilitators of colon cancer screening among patients at faith-based neighborhood health centers.

Authors:  Melissa Tabbarah; Mary Patricia Nowalk; Mahlon Raymund; Ilene K Jewell; Richard K Zimmerman
Journal:  J Community Health       Date:  2005-02

10.  Gender and race/ethnicity affect the cost-effectiveness of colorectal cancer screening.

Authors:  Charles P Theuer; Thomas H Taylor; Wendy R Brewster; Hoda Anton-Culver
Journal:  J Natl Med Assoc       Date:  2006-01       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.